Skip to content
Industry
This is research, not advice. We’re not SEBI-registered.

Medical Properties Trust share price today

Medical Properties Trust, Inc. · MPT · Real Estate · REIT - Healthcare Facilities · price as of the 4 November 2026 close, updated every trading day · results updated weekly · All US stock lists

Medical Properties Trust share price: $2.05 at the close on 4 November 2026, −59.6% in a year.

$2.05Price −59.6% in a year
5.0×P/E over 1 year
$271 MRevenue (Jun 2026) +1.9% on a year ago
−$2.3 MProfit (Jun 2026)
57.4%Operating margin −3.5 points on a year ago
−6%ROE FY25
4.6%ROIC against a 5.7% cost of capital: −1.1 points
100%Profit that came in as cash last 2 years

Medical Properties Trust, Inc.'s share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer.

Biggest thing to watch: the price is not yet in a clear uptrend, so timing is the risk more than the business.

The price has been falling for 7 weeks. Over the last four quarters, results have been mixed, and 100% of the last 2 years' profit came in as cash. What will decide it: the next one or two quarters of results.

What is the Medical Properties Trust share price today?

Medical Properties Trust, Inc.'s share price was $2.05 at the close on 4 November 2026. It has been falling for 7 weeks. That is 54.5% below its average price over the last 200 trading days. In the last 52 weeks it traded between $2 and $6, and at that close it was at the low of that range.

A share price tends to move through four phases: moving sideways (stage 1), rising (stage 2), stalling near a high (stage 3) and falling (stage 4). Today Medical Properties Trust, Inc. is in stage 4. The phase helps read everything below.

Over the past 13 weeks it has done worse than the S&P 500, and it has been behind for 35 weeks running.

1Y

Nov 2026: $2.05, 54.5% below its 200-day average. The price has been falling for 7 weeks.

  • Price $2.05
  • 50-day avg $3.29
  • 200-day avg $4.51
Nov 2026: $2.05, 54.5% below its 200-day average. The price has been falling for 7 weeks.
WeekPrice50-day avg200-day avg
31 Oct 2025$5.17$4.94$4.88
7 Nov 2025$5.07$5.01$4.90
14 Nov 2025$4.95$5.06$4.91
21 Nov 2025$5.30$5.10$4.92
28 Nov 2025$5.76$5.15$4.93
5 Dec 2025$5.48$5.22$4.95
12 Dec 2025$5.10$5.23$4.96
19 Dec 2025$5.14$5.20$4.94
26 Dec 2025$5.08$5.19$4.92
2 Jan 2026$5.08$5.18$4.91
9 Jan 2026$5.42$5.20$4.89
16 Jan 2026$5.20$5.22$4.87
23 Jan 2026$5.11$5.23$4.86
30 Jan 2026$5.02$5.24$4.85
6 Feb 2026$5.36$5.24$4.85
13 Feb 2026$5.44$5.23$4.86
20 Feb 2026$5.66$5.24$4.86
27 Feb 2026$5.76$5.29$4.88
6 Mar 2026$5.47$5.34$4.89
13 Mar 2026$4.79$5.34$4.90
20 Mar 2026$4.56$5.30$4.91
27 Mar 2026$4.53$5.23$4.91
2 Apr 2026$4.63$5.18$4.91
10 Apr 2026$4.94$5.15$4.92
17 Apr 2026$5.23$5.15$4.94
24 Apr 2026$5.14$5.12$4.96
1 May 2026$5.05$5.07$4.98
8 May 2026$5.17$5.01$5.01
15 May 2026$5.05$4.96$5.03
22 May 2026$5.08$4.94$5.05
29 May 2026$5.11$4.97$5.07
5 Jun 2026$4.98$5.00$5.09
12 Jun 2026$4.96$5.04$5.11
18 Jun 2026$4.53$5.05$5.12
26 Jun 2026$4.53$5.00$5.12
2 Jul 2026$4.59$4.95$5.11
10 Jul 2026$4.51$4.89$5.10
17 Jul 2026$4.75$4.85$5.09
24 Jul 2026$4.84$4.82$5.08
31 Jul 2026$4.63$4.78$5.07
7 Aug 2026$4.70$4.74$5.05
14 Aug 2026$4.18$4.65$5.03
21 Aug 2026$4.12$4.56$5.00
28 Aug 2026$4.09$4.48$4.98
4 Sep 2026$4.01$4.43$4.96
11 Sep 2026$3.64$4.37$4.93
18 Sep 2026$3.40$4.26$4.88
25 Sep 2026$3.57$4.16$4.83
2 Oct 2026$3.27$4.02$4.78
9 Oct 2026$3.14$3.87$4.74
16 Oct 2026$3.01$3.72$4.69
23 Oct 2026$2.70$3.57$4.63
30 Oct 2026$2.25$3.41$4.56
4 Nov 2026$2.05$3.29$4.51
Weekly closing price ($) with its 50-day and 200-day averages. The strip under the chart shows the phase: tan sideways, green rising, yellow stalling near a high, orange falling. 1-year window.

3Y

Nov 2026: $2.05, 54.5% below its 200-day average. The price has been falling for 7 weeks.

  • Price $2.05
  • 50-day avg $3.29
  • 200-day avg $4.51
Nov 2026: $2.05, 54.5% below its 200-day average. The price has been falling for 7 weeks.
WeekPrice50-day avg200-day avg
3 Nov 2023$5.45$5.65$8.43
10 Nov 2023$4.24$5.41$8.22
17 Nov 2023$4.61$5.17$8.01
24 Nov 2023$4.67$5.02$7.86
1 Dec 2023$5.21$4.92$7.67
8 Dec 2023$4.69$4.89$7.49
15 Dec 2023$5.05$4.86$7.35
22 Dec 2023$4.92$4.83$7.22
29 Dec 2023$4.91$4.83$7.15
5 Jan 2024$3.55$4.83$7.09
12 Jan 2024$3.43$4.70$6.99
19 Jan 2024$3.07$4.54$6.89
26 Jan 2024$3.27$4.42$6.77
2 Feb 2024$3.28$4.27$6.63
9 Feb 2024$3.40$4.13$6.51
16 Feb 2024$3.56$3.99$6.39
23 Feb 2024$3.84$3.91$6.30
1 Mar 2024$4.38$3.82$6.20
8 Mar 2024$4.18$3.77$6.12
15 Mar 2024$4.40$3.70$6.03
22 Mar 2024$4.10$3.74$5.92
28 Mar 2024$4.70$3.82$5.82
5 Apr 2024$4.05$3.93$5.70
12 Apr 2024$3.99$4.02$5.58
19 Apr 2024$4.42$4.16$5.47
26 Apr 2024$4.51$4.27$5.34
3 May 2024$4.87$4.37$5.21
10 May 2024$4.78$4.42$5.07
17 May 2024$5.01$4.52$4.95
24 May 2024$5.04$4.60$4.84
31 May 2024$5.36$4.66$4.78
7 Jun 2024$5.37$4.79$4.74
14 Jun 2024$4.85$4.84$4.69
21 Jun 2024$4.80$4.90$4.64
28 Jun 2024$4.31$4.92$4.59
5 Jul 2024$4.19$4.87$4.54
12 Jul 2024$4.52$4.85$4.51
19 Jul 2024$4.80$4.86$4.50
26 Jul 2024$5.31$4.87$4.50
2 Aug 2024$4.71$4.83$4.49
9 Aug 2024$4.66$4.80$4.49
16 Aug 2024$4.92$4.73$4.49
23 Aug 2024$4.51$4.68$4.48
30 Aug 2024$4.50$4.64$4.48
6 Sep 2024$4.93$4.65$4.48
13 Sep 2024$6.37$4.75$4.50
20 Sep 2024$5.76$4.93$4.52
27 Sep 2024$5.95$5.05$4.55
4 Oct 2024$5.72$5.12$4.57
11 Oct 2024$4.75$5.14$4.57
18 Oct 2024$4.99$5.15$4.57
25 Oct 2024$4.62$5.15$4.59
1 Nov 2024$4.51$5.15$4.62
8 Nov 2024$4.91$5.17$4.66
15 Nov 2024$4.31$5.13$4.69
22 Nov 2024$4.31$5.03$4.71
29 Nov 2024$4.39$4.89$4.73
6 Dec 2024$4.14$4.72$4.74
13 Dec 2024$3.98$4.55$4.74
20 Dec 2024$3.86$4.40$4.73
27 Dec 2024$3.73$4.33$4.72
3 Jan 2025$4.15$4.26$4.71
10 Jan 2025$3.83$4.20$4.71
17 Jan 2025$4.09$4.14$4.70
24 Jan 2025$4.69$4.12$4.70
31 Jan 2025$4.69$4.14$4.71
7 Feb 2025$4.77$4.20$4.71
14 Feb 2025$4.95$4.24$4.72
21 Feb 2025$4.87$4.31$4.72
28 Feb 2025$5.90$4.42$4.74
7 Mar 2025$6.02$4.60$4.75
14 Mar 2025$5.87$4.81$4.77
21 Mar 2025$5.98$5.01$4.79
28 Mar 2025$6.04$5.23$4.81
4 Apr 2025$5.24$5.38$4.83
11 Apr 2025$5.28$5.44$4.84
17 Apr 2025$5.45$5.49$4.86
25 Apr 2025$5.42$5.55$4.89
2 May 2025$5.24$5.59$4.91
9 May 2025$5.24$5.61$4.92
16 May 2025$5.07$5.54$4.91
23 May 2025$4.58$5.42$4.92
30 May 2025$4.57$5.31$4.91
6 Jun 2025$4.54$5.16$4.91
13 Jun 2025$4.41$5.00$4.91
20 Jun 2025$4.44$4.93$4.91
27 Jun 2025$4.46$4.85$4.90
3 Jul 2025$4.38$4.77$4.88
11 Jul 2025$4.13$4.65$4.83
18 Jul 2025$4.08$4.54$4.78
25 Jul 2025$4.32$4.45$4.75
1 Aug 2025$4.06$4.37$4.72
8 Aug 2025$4.08$4.32$4.71
15 Aug 2025$4.05$4.27$4.69
22 Aug 2025$4.31$4.25$4.68
29 Aug 2025$4.50$4.24$4.68
5 Sep 2025$4.61$4.25$4.68
12 Sep 2025$5.13$4.27$4.69
19 Sep 2025$5.01$4.35$4.70
26 Sep 2025$4.92$4.43$4.72
3 Oct 2025$5.54$4.53$4.75
10 Oct 2025$5.15$4.64$4.79
17 Oct 2025$5.14$4.75$4.82
24 Oct 2025$5.13$4.86$4.85
31 Oct 2025$5.17$4.94$4.88
7 Nov 2025$5.07$5.01$4.90
14 Nov 2025$4.95$5.06$4.91
21 Nov 2025$5.30$5.10$4.92
28 Nov 2025$5.76$5.15$4.93
5 Dec 2025$5.48$5.22$4.95
12 Dec 2025$5.10$5.23$4.96
19 Dec 2025$5.14$5.20$4.94
26 Dec 2025$5.08$5.19$4.92
2 Jan 2026$5.08$5.18$4.91
9 Jan 2026$5.42$5.20$4.89
16 Jan 2026$5.20$5.22$4.87
23 Jan 2026$5.11$5.23$4.86
30 Jan 2026$5.02$5.24$4.85
6 Feb 2026$5.36$5.24$4.85
13 Feb 2026$5.44$5.23$4.86
20 Feb 2026$5.66$5.24$4.86
27 Feb 2026$5.76$5.29$4.88
6 Mar 2026$5.47$5.34$4.89
13 Mar 2026$4.79$5.34$4.90
20 Mar 2026$4.56$5.30$4.91
27 Mar 2026$4.53$5.23$4.91
2 Apr 2026$4.63$5.18$4.91
10 Apr 2026$4.94$5.15$4.92
17 Apr 2026$5.23$5.15$4.94
24 Apr 2026$5.14$5.12$4.96
1 May 2026$5.05$5.07$4.98
8 May 2026$5.17$5.01$5.01
15 May 2026$5.05$4.96$5.03
22 May 2026$5.08$4.94$5.05
29 May 2026$5.11$4.97$5.07
5 Jun 2026$4.98$5.00$5.09
12 Jun 2026$4.96$5.04$5.11
18 Jun 2026$4.53$5.05$5.12
26 Jun 2026$4.53$5.00$5.12
2 Jul 2026$4.59$4.95$5.11
10 Jul 2026$4.51$4.89$5.10
17 Jul 2026$4.75$4.85$5.09
24 Jul 2026$4.84$4.82$5.08
31 Jul 2026$4.63$4.78$5.07
7 Aug 2026$4.70$4.74$5.05
14 Aug 2026$4.18$4.65$5.03
21 Aug 2026$4.12$4.56$5.00
28 Aug 2026$4.09$4.48$4.98
4 Sep 2026$4.01$4.43$4.96
11 Sep 2026$3.64$4.37$4.93
18 Sep 2026$3.40$4.26$4.88
25 Sep 2026$3.57$4.16$4.83
2 Oct 2026$3.27$4.02$4.78
9 Oct 2026$3.14$3.87$4.74
16 Oct 2026$3.01$3.72$4.69
23 Oct 2026$2.70$3.57$4.63
30 Oct 2026$2.25$3.41$4.56
4 Nov 2026$2.05$3.29$4.51
Weekly closing price ($) with its 50-day and 200-day averages. The strip under the chart shows the phase: tan sideways, green rising, yellow stalling near a high, orange falling. 3-year window.

5Y

Nov 2026: $2.05, 54.5% below its 200-day average. The price has been falling for 7 weeks.

  • Price $2.05
  • 50-day avg $3.29
  • 200-day avg $4.51
Nov 2026: $2.05, 54.5% below its 200-day average. The price has been falling for 7 weeks.
WeekPrice50-day avg200-day avg
29 Oct 2021$21.33$20.56$21.07
12 Nov 2021$21.39$20.74$21.06
26 Nov 2021$21.61$20.85$21.04
10 Dec 2021$21.84$21.08$21.02
23 Dec 2021$22.66$21.49$21.07
7 Jan 2022$23.25$22.01$21.16
21 Jan 2022$22.90$22.41$21.24
4 Feb 2022$21.90$22.59$21.27
18 Feb 2022$20.50$22.48$21.22
4 Mar 2022$20.49$22.18$21.19
18 Mar 2022$20.50$21.58$21.14
1 Apr 2022$21.54$21.05$21.11
14 Apr 2022$20.23$20.72$21.13
29 Apr 2022$18.39$20.24$21.07
13 May 2022$18.21$19.80$20.94
27 May 2022$18.58$19.42$20.84
10 Jun 2022$15.99$18.81$20.72
24 Jun 2022$15.48$17.70$20.45
8 Jul 2022$15.59$17.00$20.22
22 Jul 2022$16.55$16.52$20.00
5 Aug 2022$15.88$16.23$19.82
19 Aug 2022$15.95$15.91$19.58
2 Sep 2022$14.32$15.88$19.26
16 Sep 2022$13.80$15.65$18.93
30 Sep 2022$11.86$14.97$18.47
14 Oct 2022$10.86$13.83$17.89
28 Oct 2022$11.59$12.76$17.27
11 Nov 2022$12.55$12.05$16.69
25 Nov 2022$13.09$11.72$16.26
9 Dec 2022$11.80$11.71$15.85
23 Dec 2022$11.15$11.77$15.40
6 Jan 2023$12.36$11.89$15.06
20 Jan 2023$13.72$12.21$14.70
3 Feb 2023$12.79$12.36$14.32
17 Feb 2023$12.96$12.28$14.01
3 Mar 2023$10.53$12.14$13.68
17 Mar 2023$7.73$11.68$13.21
31 Mar 2023$8.22$10.65$12.76
14 Apr 2023$8.28$9.80$12.46
28 Apr 2023$8.77$8.98$12.10
12 May 2023$7.64$8.39$11.70
26 May 2023$7.92$8.07$11.26
9 Jun 2023$9.19$8.27$10.93
23 Jun 2023$8.68$8.41$10.67
7 Jul 2023$9.26$8.58$10.45
21 Jul 2023$10.34$8.88$10.33
4 Aug 2023$9.95$9.35$10.29
18 Aug 2023$6.93$9.30$10.15
1 Sep 2023$7.29$8.90$9.92
15 Sep 2023$6.36$8.44$9.65
29 Sep 2023$5.45$7.56$9.30
13 Oct 2023$4.96$6.57$9.00
27 Oct 2023$4.90$5.85$8.64
10 Nov 2023$4.24$5.41$8.22
24 Nov 2023$4.67$5.02$7.86
8 Dec 2023$4.69$4.89$7.49
22 Dec 2023$4.92$4.83$7.22
5 Jan 2024$3.55$4.83$7.09
19 Jan 2024$3.07$4.54$6.89
2 Feb 2024$3.28$4.27$6.63
16 Feb 2024$3.56$3.99$6.39
1 Mar 2024$4.38$3.82$6.20
15 Mar 2024$4.40$3.70$6.03
28 Mar 2024$4.70$3.82$5.82
12 Apr 2024$3.99$4.02$5.58
26 Apr 2024$4.51$4.27$5.34
10 May 2024$4.78$4.42$5.07
24 May 2024$5.04$4.60$4.84
7 Jun 2024$5.37$4.79$4.74
21 Jun 2024$4.80$4.90$4.64
5 Jul 2024$4.19$4.87$4.54
19 Jul 2024$4.80$4.86$4.50
2 Aug 2024$4.71$4.83$4.49
16 Aug 2024$4.92$4.73$4.49
30 Aug 2024$4.50$4.64$4.48
13 Sep 2024$6.37$4.75$4.50
27 Sep 2024$5.95$5.05$4.55
11 Oct 2024$4.75$5.14$4.57
25 Oct 2024$4.62$5.15$4.59
8 Nov 2024$4.91$5.17$4.66
22 Nov 2024$4.31$5.03$4.71
6 Dec 2024$4.14$4.72$4.74
20 Dec 2024$3.86$4.40$4.73
3 Jan 2025$4.15$4.26$4.71
17 Jan 2025$4.09$4.14$4.70
31 Jan 2025$4.69$4.14$4.71
14 Feb 2025$4.95$4.24$4.72
28 Feb 2025$5.90$4.42$4.74
14 Mar 2025$5.87$4.81$4.77
28 Mar 2025$6.04$5.23$4.81
11 Apr 2025$5.28$5.44$4.84
25 Apr 2025$5.42$5.55$4.89
9 May 2025$5.24$5.61$4.92
23 May 2025$4.58$5.42$4.92
6 Jun 2025$4.54$5.16$4.91
20 Jun 2025$4.44$4.93$4.91
3 Jul 2025$4.38$4.77$4.88
18 Jul 2025$4.08$4.54$4.78
1 Aug 2025$4.06$4.37$4.72
15 Aug 2025$4.05$4.27$4.69
29 Aug 2025$4.50$4.24$4.68
12 Sep 2025$5.13$4.27$4.69
26 Sep 2025$4.92$4.43$4.72
10 Oct 2025$5.15$4.64$4.79
24 Oct 2025$5.13$4.86$4.85
7 Nov 2025$5.07$5.01$4.90
21 Nov 2025$5.30$5.10$4.92
5 Dec 2025$5.48$5.22$4.95
19 Dec 2025$5.14$5.20$4.94
2 Jan 2026$5.08$5.18$4.91
16 Jan 2026$5.20$5.22$4.87
30 Jan 2026$5.02$5.24$4.85
13 Feb 2026$5.44$5.23$4.86
27 Feb 2026$5.76$5.29$4.88
13 Mar 2026$4.79$5.34$4.90
27 Mar 2026$4.53$5.23$4.91
10 Apr 2026$4.94$5.15$4.92
24 Apr 2026$5.14$5.12$4.96
8 May 2026$5.17$5.01$5.01
22 May 2026$5.08$4.94$5.05
5 Jun 2026$4.98$5.00$5.09
18 Jun 2026$4.53$5.05$5.12
2 Jul 2026$4.59$4.95$5.11
17 Jul 2026$4.75$4.85$5.09
31 Jul 2026$4.63$4.78$5.07
14 Aug 2026$4.18$4.65$5.03
28 Aug 2026$4.09$4.48$4.98
11 Sep 2026$3.64$4.37$4.93
25 Sep 2026$3.57$4.16$4.83
9 Oct 2026$3.14$3.87$4.74
23 Oct 2026$2.70$3.57$4.63
4 Nov 2026$2.05$3.29$4.51
Weekly closing price ($) with its 50-day and 200-day averages. The strip under the chart shows the phase: tan sideways, green rising, yellow stalling near a high, orange falling. 5-year window.

10Y

Nov 2026: $2.05, 54.5% below its 200-day average. The price has been falling for 7 weeks.

  • Price $2.05
  • 50-day avg $3.29
  • 200-day avg $4.51
Nov 2026: $2.05, 54.5% below its 200-day average. The price has been falling for 7 weeks.
WeekPrice50-day avg200-day avg
28 Oct 2016$13.69$14.69–
18 Nov 2016$12.28$13.84–
9 Dec 2016$12.43$13.19–
30 Dec 2016$12.30$12.56–
20 Jan 2017$12.63$12.28–
10 Feb 2017$13.25$12.48–
3 Mar 2017$12.89$12.79–
24 Mar 2017$12.75$12.83–
13 Apr 2017$13.90$12.97–
5 May 2017$12.97$13.09$13.52
26 May 2017$12.80$13.22$13.34
16 Jun 2017$13.20$13.35$13.19
7 Jul 2017$12.43$13.11$13.08
28 Jul 2017$12.93$13.03$12.95
18 Aug 2017$12.51$12.90$12.82
8 Sep 2017$13.32$12.82$12.88
29 Sep 2017$13.13$12.93$12.94
20 Oct 2017$13.33$13.03$13.02
10 Nov 2017$13.56$13.22$13.07
1 Dec 2017$13.80$13.38$13.12
22 Dec 2017$13.59$13.57$13.18
12 Jan 2018$12.76$13.61$13.23
2 Feb 2018$12.61$13.44$13.19
23 Feb 2018$12.66$13.07$13.13
16 Mar 2018$12.89$12.78$13.10
6 Apr 2018$12.69$12.68$13.06
27 Apr 2018$12.81$12.68$13.04
18 May 2018$13.03$12.84$13.06
8 Jun 2018$13.96$13.03$13.12
29 Jun 2018$14.04$13.41$13.18
20 Jul 2018$14.18$13.82$13.27
10 Aug 2018$14.38$14.15$13.36
31 Aug 2018$15.05$14.45$13.46
21 Sep 2018$14.69$14.64$13.54
12 Oct 2018$14.06$14.70$13.59
2 Nov 2018$15.34$14.72$13.71
23 Nov 2018$16.47$15.16$13.97
14 Dec 2018$16.85$15.84$14.29
4 Jan 2019$16.05$16.27$14.50
25 Jan 2019$17.54$16.62$14.79
15 Feb 2019$18.36$17.05$15.20
8 Mar 2019$18.04$17.50$15.56
29 Mar 2019$18.51$18.14$15.92
18 Apr 2019$17.24$18.39$16.24
10 May 2019$17.88$18.15$16.48
31 May 2019$17.78$18.11$16.74
21 Jun 2019$18.21$17.94$16.98
12 Jul 2019$18.51$18.04$17.21
2 Aug 2019$17.87$17.98$17.46
23 Aug 2019$18.31$17.97$17.69
13 Sep 2019$18.46$18.21$17.84
4 Oct 2019$19.47$18.56$18.02
25 Oct 2019$20.45$19.23$18.30
15 Nov 2019$20.25$19.67$18.51
6 Dec 2019$21.27$20.11$18.68
27 Dec 2019$20.71$20.38$18.84
17 Jan 2020$22.29$20.65$19.03
7 Feb 2020$23.28$21.38$19.34
28 Feb 2020$21.13$22.10$19.74
20 Mar 2020$14.07$21.57$19.80
9 Apr 2020$18.29$19.94$19.67
1 May 2020$16.67$17.94$19.56
22 May 2020$17.47$16.43$19.51
12 Jun 2020$19.38$17.44$19.58
2 Jul 2020$19.03$18.12$19.60
24 Jul 2020$18.92$18.63$19.53
14 Aug 2020$19.18$19.19$19.51
4 Sep 2020$18.40$18.95$19.40
25 Sep 2020$17.14$18.71$19.18
16 Oct 2020$18.05$18.36$19.02
6 Nov 2020$18.79$18.10$18.76
27 Nov 2020$19.57$18.39$18.51
18 Dec 2020$21.08$19.26$18.32
8 Jan 2021$21.07$20.08$18.64
29 Jan 2021$21.11$20.76$18.94
19 Feb 2021$21.86$21.42$19.33
12 Mar 2021$21.94$21.54$19.66
1 Apr 2021$21.66$21.62$19.80
23 Apr 2021$22.64$21.73$20.04
14 May 2021$20.82$21.65$20.26
4 Jun 2021$21.10$21.56$20.36
25 Jun 2021$20.50$21.38$20.54
16 Jul 2021$20.62$20.86$20.74
6 Aug 2021$20.31$20.74$20.92
27 Aug 2021$20.08$20.32$21.03
17 Sep 2021$20.07$20.50$21.14
8 Oct 2021$19.72$20.40$21.10
29 Oct 2021$21.33$20.56$21.07
19 Nov 2021$21.67$20.76$21.06
10 Dec 2021$21.84$21.08$21.02
31 Dec 2021$23.63$21.75$21.10
21 Jan 2022$22.90$22.41$21.24
11 Feb 2022$21.67$22.61$21.24
4 Mar 2022$20.49$22.18$21.19
25 Mar 2022$20.67$21.27$21.11
14 Apr 2022$20.23$20.72$21.13
6 May 2022$18.42$20.07$21.01
27 May 2022$18.58$19.42$20.84
17 Jun 2022$14.36$18.17$20.58
8 Jul 2022$15.59$17.00$20.22
29 Jul 2022$17.24$16.41$19.92
19 Aug 2022$15.95$15.91$19.58
9 Sep 2022$14.85$15.79$19.12
30 Sep 2022$11.86$14.97$18.47
21 Oct 2022$10.22$13.30$17.57
11 Nov 2022$12.55$12.05$16.69
2 Dec 2022$13.01$11.69$16.05
23 Dec 2022$11.15$11.77$15.40
13 Jan 2023$12.83$12.02$14.86
3 Feb 2023$12.79$12.36$14.32
24 Feb 2023$10.55$12.26$13.87
17 Mar 2023$7.73$11.68$13.21
6 Apr 2023$8.10$10.24$12.63
28 Apr 2023$8.77$8.98$12.10
19 May 2023$7.68$8.13$11.47
9 Jun 2023$9.19$8.27$10.93
30 Jun 2023$9.26$8.48$10.53
21 Jul 2023$10.34$8.88$10.33
11 Aug 2023$8.08$9.42$10.24
1 Sep 2023$7.29$8.90$9.92
22 Sep 2023$5.34$8.05$9.47
13 Oct 2023$4.96$6.57$9.00
3 Nov 2023$5.45$5.65$8.43
24 Nov 2023$4.67$5.02$7.86
15 Dec 2023$5.05$4.86$7.35
5 Jan 2024$3.55$4.83$7.09
26 Jan 2024$3.27$4.42$6.77
16 Feb 2024$3.56$3.99$6.39
8 Mar 2024$4.18$3.77$6.12
28 Mar 2024$4.70$3.82$5.82
19 Apr 2024$4.42$4.16$5.47
10 May 2024$4.78$4.42$5.07
31 May 2024$5.36$4.66$4.78
21 Jun 2024$4.80$4.90$4.64
12 Jul 2024$4.52$4.85$4.51
2 Aug 2024$4.71$4.83$4.49
23 Aug 2024$4.51$4.68$4.48
13 Sep 2024$6.37$4.75$4.50
4 Oct 2024$5.72$5.12$4.57
25 Oct 2024$4.62$5.15$4.59
15 Nov 2024$4.31$5.13$4.69
6 Dec 2024$4.14$4.72$4.74
27 Dec 2024$3.73$4.33$4.72
17 Jan 2025$4.09$4.14$4.70
7 Feb 2025$4.77$4.20$4.71
28 Feb 2025$5.90$4.42$4.74
21 Mar 2025$5.98$5.01$4.79
11 Apr 2025$5.28$5.44$4.84
2 May 2025$5.24$5.59$4.91
23 May 2025$4.58$5.42$4.92
13 Jun 2025$4.41$5.00$4.91
3 Jul 2025$4.38$4.77$4.88
25 Jul 2025$4.32$4.45$4.75
15 Aug 2025$4.05$4.27$4.69
5 Sep 2025$4.61$4.25$4.68
26 Sep 2025$4.92$4.43$4.72
17 Oct 2025$5.14$4.75$4.82
7 Nov 2025$5.07$5.01$4.90
28 Nov 2025$5.76$5.15$4.93
19 Dec 2025$5.14$5.20$4.94
9 Jan 2026$5.42$5.20$4.89
30 Jan 2026$5.02$5.24$4.85
20 Feb 2026$5.66$5.24$4.86
13 Mar 2026$4.79$5.34$4.90
2 Apr 2026$4.63$5.18$4.91
24 Apr 2026$5.14$5.12$4.96
15 May 2026$5.05$4.96$5.03
5 Jun 2026$4.98$5.00$5.09
26 Jun 2026$4.53$5.00$5.12
17 Jul 2026$4.75$4.85$5.09
7 Aug 2026$4.70$4.74$5.05
28 Aug 2026$4.09$4.48$4.98
18 Sep 2026$3.40$4.26$4.88
9 Oct 2026$3.14$3.87$4.74
30 Oct 2026$2.25$3.41$4.56
4 Nov 2026$2.05$3.29$4.51
Weekly closing price ($) with its 50-day and 200-day averages. The strip under the chart shows the phase: tan sideways, green rising, yellow stalling near a high, orange falling. 10-year window.

Price stage: Sideways from Oct 2025 to Feb 2026; Rising from Feb 2026 to Mar 2026; Sideways from Mar 2026 to Apr 2026; Rising from Apr 2026 to May 2026; Sideways from Jun 2026 to Sep 2026; Falling from Sep 2026 to Nov 2026.

Price stage: Falling from Nov 2023 to May 2024; Sideways from May 2024 to Nov 2024; Falling from Nov 2024 to Dec 2024; Sideways in Jan 2025; Rising from Feb 2025 to May 2025; Sideways from May 2025 to Sep 2025; Sideways from Sep 2025 to Feb 2026; Rising from Feb 2026 to Mar 2026; Sideways from Mar 2026 to Apr 2026; Rising from Apr 2026 to May 2026; Sideways from Jun 2026 to Sep 2026; Falling from Sep 2026 to Nov 2026.

Price stage: Rising from Oct 2021 to Feb 2022; Sideways from Feb 2022 to May 2022; Falling from May 2022 to May 2024; Sideways from May 2024 to Nov 2024; Falling from Nov 2024 to Dec 2024; Sideways in Jan 2025; Rising from Feb 2025 to May 2025; Sideways from May 2025 to Aug 2025; Sideways from Sep 2025 to Mar 2026; Rising from Apr 2026 to May 2026; Sideways from Jun 2026 to Sep 2026; Falling from Sep 2026 to Nov 2026.

Price stage: Sideways from Dec 2017 to May 2018; Sideways from Jun 2018 to Aug 2018; Rising from Aug 2018 to Feb 2020; Sideways from Mar 2020 to Oct 2020; Sideways from Nov 2020 to Mar 2021; Rising from Apr 2021 to Jun 2021; Sideways from Jun 2021 to Oct 2021; Rising from Oct 2021 to Feb 2022; Sideways from Mar 2022 to May 2022; Falling from May 2022 to May 2024; Sideways from May 2024 to Oct 2024; Falling from Nov 2024 to Jan 2025; Rising from Feb 2025 to May 2025; Sideways from May 2025 to Nov 2025; Sideways from Nov 2025 to May 2026; Sideways from Jun 2026 to Sep 2026; Falling from Oct 2026 to Nov 2026.

Week by week since 2016: did it beat the S&P 500 over the past 13 weeks?

Ahead in 191 of 527 weeks

Week by week since 2016: did it beat the S&P 500 over the past 13 weeks?
Week13-week return vs S&P 500
8 Jul 2016no S&P 500 reading
15 Jul 2016no S&P 500 reading
22 Jul 2016no S&P 500 reading
29 Jul 2016no S&P 500 reading
5 Aug 2016no S&P 500 reading
12 Aug 2016no S&P 500 reading
19 Aug 2016no S&P 500 reading
26 Aug 2016no S&P 500 reading
2 Sep 2016no S&P 500 reading
9 Sep 2016no S&P 500 reading
16 Sep 2016no S&P 500 reading
23 Sep 2016no S&P 500 reading
30 Sep 2016no S&P 500 reading
7 Oct 2016−7.2%
14 Oct 2016−2.3%
21 Oct 2016−5.1%
28 Oct 2016−10.7%
4 Nov 2016−17.3%
11 Nov 2016−21.2%
18 Nov 2016−20.2%
25 Nov 2016−20.0%
2 Dec 2016−22.6%
9 Dec 2016−18.0%
16 Dec 2016−19.0%
23 Dec 2016−23.8%
30 Dec 2016−20.1%
6 Jan 2017−17.5%
13 Jan 2017−19.7%
20 Jan 2017−20.4%
27 Jan 2017−14.0%
3 Feb 2017−3.3%
10 Feb 2017+3.4%
17 Feb 2017+0.6%
24 Feb 2017+1.1%
3 Mar 2017+0.1%
10 Mar 2017−6.8%
17 Mar 2017−3.4%
24 Mar 2017+2.0%
31 Mar 2017−0.7%
7 Apr 2017+5.3%
13 Apr 2017+7.7%
21 Apr 2017+7.6%
28 Apr 2017−2.1%
5 May 2017−4.1%
12 May 2017−2.6%
19 May 2017−2.0%
26 May 2017−6.3%
2 Jun 2017+0.3%
9 Jun 2017+7.0%
16 Jun 2017+4.0%
23 Jun 2017−0.1%
30 Jun 2017−2.7%
7 Jul 2017−11.7%
14 Jul 2017−14.4%
21 Jul 2017−11.9%
28 Jul 2017−4.8%
4 Aug 2017−4.5%
11 Aug 2017−8.2%
18 Aug 2017−7.1%
25 Aug 2017−1.1%
1 Sep 2017−2.0%
8 Sep 2017−1.5%
15 Sep 2017−2.9%
22 Sep 2017−4.9%
29 Sep 2017−1.9%
6 Oct 2017−0.1%
13 Oct 2017−1.0%
20 Oct 2017−2.4%
27 Oct 2017−1.7%
3 Nov 2017+1.7%
10 Nov 2017+2.6%
17 Nov 2017+3.9%
24 Nov 2017+1.3%
1 Dec 2017−1.9%
8 Dec 2017−5.7%
15 Dec 2017−0.8%
22 Dec 2017−2.2%
29 Dec 2017−1.3%
5 Jan 2018−5.7%
12 Jan 2018−11.2%
19 Jan 2018−12.3%
26 Jan 2018−12.3%
2 Feb 2018−13.8%
9 Feb 2018−9.6%
16 Feb 2018−13.0%
23 Feb 2018−13.8%
2 Mar 2018−10.7%
9 Mar 2018−8.9%
16 Mar 2018−10.7%
23 Mar 2018−4.6%
29 Mar 2018−4.3%
6 Apr 2018+0.6%
13 Apr 2018+2.9%
20 Apr 2018+1.4%
27 Apr 2018+4.5%
4 May 2018+7.5%
11 May 2018+3.3%
18 May 2018+2.4%
25 May 2018+6.1%
1 Jun 2018+6.8%
8 Jun 2018+7.1%
15 Jun 2018+6.8%
22 Jun 2018+6.6%
29 Jun 2018+4.9%
6 Jul 2018+7.8%
13 Jul 2018+8.8%
20 Jul 2018+9.1%
27 Jul 2018+4.1%
3 Aug 2018+4.4%
10 Aug 2018+3.6%
17 Aug 2018+9.5%
24 Aug 2018+6.4%
31 Aug 2018+4.4%
7 Sep 2018+3.3%
14 Sep 2018+0.4%
21 Sep 2018−2.2%
28 Sep 2018−1.0%
5 Oct 2018−5.6%
12 Oct 2018−0.7%
19 Oct 2018+5.0%
26 Oct 2018+10.8%
2 Nov 2018+9.3%
9 Nov 2018+18.2%
16 Nov 2018+15.2%
23 Nov 2018+18.9%
30 Nov 2018+19.8%
7 Dec 2018+22.3%
14 Dec 2018+25.4%
21 Dec 2018+28.2%
28 Dec 2018+22.2%
4 Jan 2019+24.6%
11 Jan 2019+24.2%
18 Jan 2019+19.6%
25 Jan 2019+18.7%
1 Feb 2019+15.9%
8 Feb 2019+13.0%
15 Feb 2019+9.2%
22 Feb 2019+6.3%
1 Mar 2019+3.0%
8 Mar 2019+2.2%
15 Mar 2019+0.6%
22 Mar 2019−1.9%
29 Mar 2019+1.6%
5 Apr 2019+2.5%
12 Apr 2019+1.0%
18 Apr 2019−8.0%
26 Apr 2019−10.7%
3 May 2019−6.4%
10 May 2019−9.7%
17 May 2019−3.7%
24 May 2019+0.1%
31 May 2019+0.2%
7 Jun 2019−3.2%
14 Jun 2019−4.2%
21 Jun 2019−7.1%
28 Jun 2019−9.5%
5 Jul 2019−5.9%
12 Jul 2019−4.9%
19 Jul 2019−1.0%
26 Jul 2019−1.0%
2 Aug 2019−0.8%
9 Aug 2019+0.1%
16 Aug 2019−1.5%
23 Aug 2019−3.1%
30 Aug 2019−1.7%
6 Sep 2019+1.2%
13 Sep 2019−1.8%
20 Sep 2019+3.1%
27 Sep 2019+10.8%
4 Oct 2019+7.8%
11 Oct 2019+8.3%
18 Oct 2019+14.7%
25 Oct 2019+14.9%
1 Nov 2019+11.9%
8 Nov 2019+4.2%
15 Nov 2019+3.6%
22 Nov 2019−1.6%
29 Nov 2019+4.2%
6 Dec 2019+5.0%
13 Dec 2019+2.2%
20 Dec 2019+1.2%
27 Dec 2019−2.9%
3 Jan 2020−2.0%
10 Jan 2020−2.3%
17 Jan 2020−0.5%
24 Jan 2020+0.5%
31 Jan 2020+1.3%
7 Feb 2020+9.2%
14 Feb 2020+10.6%
21 Feb 2020+15.3%
28 Feb 2020+7.5%
6 Mar 2020+13.8%
13 Mar 2020+5.3%
20 Mar 2020−3.4%
27 Mar 2020+6.9%
3 Apr 2020−8.2%
9 Apr 2020+0.5%
17 Apr 2020−9.3%
24 Apr 2020−15.2%
1 May 2020−12.6%
8 May 2020−11.1%
15 May 2020−18.2%
22 May 2020−16.3%
29 May 2020−17.2%
5 Jun 2020−20.3%
12 Jun 2020−4.8%
19 Jun 2020+1.9%
26 Jun 2020−15.1%
2 Jul 2020+6.3%
10 Jul 2020−17.2%
17 Jul 2020−2.9%
24 Jul 2020+5.8%
31 Jul 2020+5.3%
7 Aug 2020−3.4%
14 Aug 2020+2.0%
21 Aug 2020−9.7%
28 Aug 2020−12.5%
4 Sep 2020−15.5%
11 Sep 2020−15.8%
18 Sep 2020−18.8%
25 Sep 2020−15.7%
2 Oct 2020−9.4%
9 Oct 2020−4.4%
16 Oct 2020−11.8%
23 Oct 2020−11.0%
30 Oct 2020−11.5%
6 Nov 2020−10.1%
13 Nov 2020−5.2%
20 Nov 2020+1.0%
27 Nov 2020+1.7%
4 Dec 2020+3.8%
11 Dec 2020+3.9%
18 Dec 2020+12.3%
24 Dec 2020+14.5%
31 Dec 2020+5.4%
8 Jan 2021+3.4%
15 Jan 2021+9.2%
22 Jan 2021+6.6%
29 Jan 2021+5.1%
5 Feb 2021+5.7%
12 Feb 2021+6.3%
19 Feb 2021+2.7%
26 Feb 2021+5.7%
5 Mar 2021−0.4%
12 Mar 2021−1.5%
19 Mar 2021−6.2%
26 Mar 2021−9.1%
1 Apr 2021−7.7%
9 Apr 2021−5.3%
16 Apr 2021−6.6%
23 Apr 2021−3.4%
30 Apr 2021−8.3%
7 May 2021−10.7%
14 May 2021−13.6%
21 May 2021−10.3%
28 May 2021−12.4%
4 Jun 2021−10.8%
11 Jun 2021−8.5%
18 Jun 2021−11.8%
25 Jun 2021−11.7%
2 Jul 2021−13.2%
9 Jul 2021−11.1%
16 Jul 2021−10.2%
23 Jul 2021−12.8%
30 Jul 2021−9.7%
6 Aug 2021−10.3%
13 Aug 2021−10.4%
20 Aug 2021−12.0%
27 Aug 2021−12.3%
3 Sep 2021−4.6%
10 Sep 2021−8.2%
17 Sep 2021−5.1%
24 Sep 2021−3.0%
1 Oct 2021−1.9%
8 Oct 2021−4.3%
15 Oct 2021−2.3%
22 Oct 2021−4.8%
29 Oct 2021−3.3%
5 Nov 2021−2.0%
12 Nov 2021+1.5%
19 Nov 2021+3.1%
26 Nov 2021+5.7%
3 Dec 2021−1.4%
10 Dec 2021−2.0%
17 Dec 2021+6.8%
23 Dec 2021+3.4%
31 Dec 2021+7.4%
7 Jan 2022+11.5%
14 Jan 2022+11.6%
21 Jan 2022+14.4%
28 Jan 2022+8.1%
4 Feb 2022+8.1%
11 Feb 2022+7.0%
18 Feb 2022+2.0%
25 Feb 2022+0.8%
4 Mar 2022+0.6%
11 Mar 2022+3.0%
18 Mar 2022−4.6%
25 Mar 2022−5.0%
1 Apr 2022−4.2%
8 Apr 2022−5.3%
14 Apr 2022−10.4%
22 Apr 2022−15.4%
29 Apr 2022−10.6%
6 May 2022−7.6%
13 May 2022−7.2%
20 May 2022−1.6%
27 May 2022−5.4%
3 Jun 2022−10.4%
10 Jun 2022−13.4%
17 Jun 2022−12.3%
24 Jun 2022−11.3%
1 Jul 2022−11.6%
8 Jul 2022−13.0%
15 Jul 2022−10.0%
22 Jul 2022−4.5%
29 Jul 2022−6.3%
5 Aug 2022−14.3%
12 Aug 2022−14.5%
19 Aug 2022−20.1%
26 Aug 2022−17.0%
2 Sep 2022−12.9%
9 Sep 2022−11.4%
16 Sep 2022−9.3%
23 Sep 2022−13.7%
30 Sep 2022−17.9%
7 Oct 2022−28.3%
14 Oct 2022−24.0%
21 Oct 2022−33.0%
28 Oct 2022−27.2%
4 Nov 2022−20.1%
11 Nov 2022−18.2%
18 Nov 2022−16.3%
25 Nov 2022−11.8%
2 Dec 2022−12.9%
9 Dec 2022−17.3%
16 Dec 2022−16.9%
23 Dec 2022−14.7%
30 Dec 2022−13.1%
6 Jan 2023+14.9%
13 Jan 2023+6.7%
20 Jan 2023+28.5%
27 Jan 2023+8.4%
3 Feb 2023+4.0%
10 Feb 2023−6.1%
17 Feb 2023+1.9%
24 Feb 2023−17.9%
3 Mar 2023−18.4%
10 Mar 2023−23.6%
17 Mar 2023−33.9%
24 Mar 2023−35.8%
31 Mar 2023−33.3%
6 Apr 2023−39.9%
14 Apr 2023−39.0%
21 Apr 2023−43.6%
28 Apr 2023−35.4%
5 May 2023−32.7%
12 May 2023−37.7%
19 May 2023−43.5%
26 May 2023−30.9%
2 Jun 2023−27.5%
9 Jun 2023−6.8%
16 Jun 2023+6.1%
23 Jun 2023+5.8%
30 Jun 2023+4.4%
7 Jul 2023+7.1%
14 Jul 2023+9.9%
21 Jul 2023+14.7%
28 Jul 2023+4.7%
4 Aug 2023+7.3%
11 Aug 2023−2.5%
18 Aug 2023−14.0%
25 Aug 2023−16.2%
1 Sep 2023−17.1%
8 Sep 2023−31.4%
15 Sep 2023−31.6%
22 Sep 2023−37.8%
29 Sep 2023−37.6%
6 Oct 2023−42.9%
13 Oct 2023−45.6%
20 Oct 2023−47.7%
27 Oct 2023−41.1%
3 Nov 2023−42.5%
10 Nov 2023−46.4%
17 Nov 2023−36.8%
24 Nov 2023−36.9%
1 Dec 2023−30.3%
8 Dec 2023−32.7%
15 Dec 2023−26.5%
22 Dec 2023−17.9%
29 Dec 2023−21.1%
5 Jan 2024−39.3%
12 Jan 2024−41.3%
19 Jan 2024−49.2%
26 Jan 2024−51.9%
2 Feb 2024−53.5%
9 Feb 2024−33.6%
16 Feb 2024−33.6%
23 Feb 2024−29.3%
1 Mar 2024−27.6%
8 Mar 2024−22.1%
15 Mar 2024−21.5%
22 Mar 2024−26.7%
28 Mar 2024−14.3%
5 Apr 2024+3.3%
12 Apr 2024+9.2%
19 Apr 2024+41.3%
26 Apr 2024+33.6%
3 May 2024+45.0%
10 May 2024+36.7%
17 May 2024+34.7%
24 May 2024+27.0%
31 May 2024+19.5%
7 Jun 2024+24.1%
14 Jun 2024+3.8%
21 Jun 2024+12.6%
28 Jun 2024−12.3%
5 Jul 2024−3.5%
12 Jul 2024+3.7%
19 Jul 2024−2.3%
26 Jul 2024+10.6%
2 Aug 2024−7.5%
9 Aug 2024−4.8%
16 Aug 2024−6.5%
23 Aug 2024−16.7%
30 Aug 2024−22.9%
6 Sep 2024−9.4%
13 Sep 2024+27.8%
20 Sep 2024+15.6%
27 Sep 2024+33.0%
4 Oct 2024+33.2%
11 Oct 2024+1.6%
18 Oct 2024−2.5%
25 Oct 2024−19.3%
1 Nov 2024−11.4%
8 Nov 2024−6.9%
15 Nov 2024−18.1%
22 Nov 2024−10.4%
29 Nov 2024−9.3%
6 Dec 2024−28.5%
13 Dec 2024−45.0%
20 Dec 2024−37.0%
27 Dec 2024−41.4%
3 Jan 2025−30.8%
10 Jan 2025−19.5%
17 Jan 2025−20.3%
24 Jan 2025−3.5%
31 Jan 2025−1.4%
7 Feb 2025−3.3%
14 Feb 2025+10.8%
21 Feb 2025+12.2%
28 Feb 2025+35.8%
7 Mar 2025+50.7%
14 Mar 2025+54.3%
21 Mar 2025+59.5%
28 Mar 2025+68.5%
4 Apr 2025+40.9%
11 Apr 2025+45.9%
17 Apr 2025+45.2%
25 Apr 2025+25.0%
2 May 2025+17.6%
9 May 2025+15.9%
16 May 2025+5.0%
23 May 2025−2.5%
30 May 2025−21.7%
6 Jun 2025−28.6%
13 Jun 2025−30.9%
20 Jun 2025−31.1%
27 Jun 2025−36.8%
3 Jul 2025−40.2%
11 Jul 2025−38.6%
18 Jul 2025−44.4%
25 Jul 2025−36.0%
1 Aug 2025−32.2%
8 Aug 2025−35.0%
15 Aug 2025−28.4%
22 Aug 2025−17.3%
29 Aug 2025−11.0%
5 Sep 2025−6.5%
12 Sep 2025+6.2%
19 Sep 2025+1.2%
26 Sep 2025+2.7%
3 Oct 2025+19.5%
10 Oct 2025+20.0%
17 Oct 2025+20.1%
24 Oct 2025+12.4%
31 Oct 2025+17.6%
7 Nov 2025+19.0%
14 Nov 2025+17.8%
21 Nov 2025+20.8%
28 Nov 2025+22.1%
5 Dec 2025+12.9%
12 Dec 2025−4.3%
19 Dec 2025+0.0%
26 Dec 2025−1.1%
2 Jan 2026−10.4%
9 Jan 2026−1.0%
16 Jan 2026−2.9%
23 Jan 2026−2.2%
30 Jan 2026−4.4%
6 Feb 2026+2.8%
13 Feb 2026+8.4%
20 Feb 2026+2.2%
27 Feb 2026−0.4%
6 Mar 2026+1.8%
13 Mar 2026−3.2%
20 Mar 2026−6.6%
27 Mar 2026−2.7%
2 Apr 2026−4.9%
10 Apr 2026−6.8%
17 Apr 2026−2.1%
24 Apr 2026−3.0%
1 May 2026−3.5%
8 May 2026−10.4%
15 May 2026−15.6%
22 May 2026−18.4%
29 May 2026−21.6%
5 Jun 2026−18.7%
12 Jun 2026−8.4%
18 Jun 2026−15.8%
26 Jun 2026−15.0%
2 Jul 2026−14.4%
10 Jul 2026−19.8%
17 Jul 2026−13.8%
24 Jul 2026−9.3%
31 Jul 2026−12.0%
7 Aug 2026−13.9%
14 Aug 2026−22.3%
21 Aug 2026−21.6%
28 Aug 2026−21.7%
4 Sep 2026−23.9%
11 Sep 2026−29.7%
18 Sep 2026−26.9%
25 Sep 2026−27.0%
2 Oct 2026−32.1%
9 Oct 2026−33.5%
16 Oct 2026−39.3%
23 Oct 2026−47.1%
30 Oct 2026−52.6%
4 Nov 2026−55.5%
Each bar is one week, from 2016 to now (527 weeks with a reading). Green means the stock's return over the previous 13 weeks beat the S&P 500; red means it trailed. The colour is strongest at a gap of 25 percentage points or more. A gap means there is no reading for that week.

Over the last 10 years the share price moved −86% while the S&P 500 moved +261%, so it is behind the index over that whole period. It was last ahead over 13 weeks in the week of 6 March 2026. The chart above shows the 13-week comparison for every week.

This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row.

What dividend does Medical Properties Trust pay?

Medical Properties Trust, Inc. paid $0.35 per share over the last four reported quarters. The most recent declaration was $0.09 for Jun 2026. At today's price of $2.05 that is a yield of 17.07%, based on dividends already paid, not a forecast.

A dividend is cash paid out for each share. The 12-month total is the four most recent quarters added together.

Dividend per share each quarter: latest $0.09 (Jun 2026)

  • Dividend per share $0.09
Dividend per share each quarter: latest $0.09 (Jun 2026)
QuarterDividend per share
Sep 2023$0.15
Dec 2023$0.15
Mar 2024$0.15
Jun 2024$0.15
Sep 2024$0.08
Dec 2024$0.08
Mar 2025$0.08
Jun 2025$0.08
Sep 2025$0.08
Dec 2025$0.09
Mar 2026$0.09
Jun 2026$0.09
Declared dividend per share, $ a share, each reported quarter. 12 quarters on file.

Which stock lists is Medical Properties Trust on?

Medical Properties Trust is not in the Nasdaq 100, the S&P 500 or the Dow Jones 30, and is not on the US tech stocks list.

Is Medical Properties Trust profitable?

Medical Properties Trust, Inc. posted a net loss of $2.3 M in the Jun 2026 quarter. The full FY25 year was a loss of $278 M. That loss is 0.8% of the quarter's revenue. The same quarter a year earlier lost $98.1 M. 9 of the last 12 reported quarters were loss-making.

Net profit is what is left after every cost, interest and tax. Earnings per share, dividends and book value all grow from it.

FY25 profit −$278 M

  • Net profit −$278 M
FY25 profit −$278 M
QuarterNet profit
FY21$654 M
FY22$901 M
FY23−$558 M
FY24−$2.4 B
FY25−$278 M

Growth on a year earlier

  • Growth on a year earlier −161.9%
Growth on a year earlier
QuarterGrowth on a year earlier
FY21–
FY2237.8%
FY23−161.9%
FY24–
FY25–
Top: net profit each year, $ B. Below: growth on the year before, %. 5-year window. A grey bar is lower than the year before.

Jun 2026: −$2.3 M

  • Net profit (quarterly) −$2.3 M
Jun 2026: −$2.3 M
QuarterNet profit (quarterly)
Sep 2023$117 M
Dec 2023−$664 M
Mar 2024−$875 M
Jun 2024−$320 M
Sep 2024−$801 M
Dec 2024−$412 M
Mar 2025−$118 M
Jun 2025−$98.1 M
Sep 2025−$77.5 M
Dec 2025$17.6 M
Mar 2026$33.1 M
Jun 2026−$2.3 M

Growth on a year earlier

  • Growth on a year earlier −785.2%
Growth on a year earlier
QuarterGrowth on a year earlier
Sep 2023−47.3%
Dec 2023–
Mar 2024−2,750.2%
Jun 2024–
Sep 2024−785.2%
Dec 2024–
Mar 2025–
Jun 2025–
Sep 2025–
Dec 2025–
Mar 2026–
Jun 2026–
Top: net profit each quarter, $ M. Below: growth on the same quarter a year earlier, %. Last 12 quarters. A grey bar is lower than the quarter before.

How much revenue does Medical Properties Trust make, and is it growing?

Medical Properties Trust, Inc. reported $271 M of revenue in the Jun 2026 quarter, +1.9% on the same quarter a year earlier. That is the 4th quarter in a row with growth on the year before. Over 4 years it has grown −9.2% a year on average. The last full year, FY25, came in at $1.1 B.

Revenue is everything the company billed its customers in the period.

The last four reported quarters add to $1.1 B.

FY25 revenue was $1.1 B, +2.9% on the year before.

FY25 revenue $1.1 B (+2.9% on the year before), −9.2% a year over 4 years

  • Revenue $1.1 B
FY25 revenue $1.1 B (+2.9% on the year before), −9.2% a year over 4 years
QuarterRevenue
FY21$1.6 B
FY22$1.6 B
FY23$886 M
FY24$1.0 B
FY25$1.1 B

Growth on a year earlier

  • Growth on a year earlier 2.9%
Growth on a year earlier
QuarterGrowth on a year earlier
FY21–
FY220.7%
FY23−44.1%
FY2417.4%
FY252.9%
Top: revenue each year, $ B. Below: growth on the year before, %. 5-year window. A grey bar is lower than the year before.

Jun 2026: $271 M (+1.9% on a year earlier), the 4th quarter in a row of growth

  • Revenue (quarterly) $271 M
Jun 2026: $271 M (+1.9% on a year earlier), the 4th quarter in a row of growth
QuarterRevenue (quarterly)
Sep 2023$318 M
Dec 2023−$143 M
Mar 2024$282 M
Jun 2024$276 M
Sep 2024$247 M
Dec 2024$235 M
Mar 2025$238 M
Jun 2025$266 M
Sep 2025$272 M
Dec 2025$294 M
Mar 2026$268 M
Jun 2026$271 M

Growth on a year earlier

  • Growth on a year earlier 1.9%
Growth on a year earlier
QuarterGrowth on a year earlier
Sep 2023−12.6%
Dec 2023−137%
Mar 2024−22%
Jun 2024−21.2%
Sep 2024−22.1%
Dec 2024–
Mar 2025−15.6%
Jun 2025−3.6%
Sep 20259.9%
Dec 202525.4%
Mar 202612.6%
Jun 20261.9%
Top: revenue each quarter, $ M. Below: growth on the same quarter a year earlier, %. Last 12 quarters. A grey bar is lower than the quarter before.

Recent pace: the last four quarters grew +12.4% on average, against −9.2% a year over the longer run, so this year is growing faster than its own long-run rate.

Is growth speeding up? Revenue over the last 12 months grew +12.1%, against +22.9% a year over the last 8 quarters (rolling over).

How much of every $100 of sales does Medical Properties Trust keep?

Medical Properties Trust, Inc.'s operating margin was 57.4% in the Jun 2026 quarter, 3.5 percentage points lower than the same quarter a year ago. Across 5 years it has been between 6.5% and 67.8%. The latest quarter is within that range.

Operating margin is what is left from every $100 of sales after the costs of running the business, before interest and tax. It shows pricing power and cost control.

Why: the operating margin move is clear, but the cost details behind it are not in our data, so we show the move without guessing the reason.

FY25: 59.6%, within a range of 6.5% to 67.8% over 5 years

  • Operating margin 59.6%
FY25: 59.6%, within a range of 6.5% to 67.8% over 5 years
QuarterOperating margin
FY2167.8%
FY2266%
FY236.5%
FY2441.5%
FY2559.6%

Change on the year before (points)

  • Change on the year before (points) +18.1 pts
Change on the year before (points)
QuarterChange on the year before (points)
FY21–
FY22−1.8 pts
FY23−59.5 pts
FY24+35.0 pts
FY25+18.1 pts
Operating margin each year, % (top). Below: change on the year before, in percentage points. 5-year window.

Jun 2026: operating margin 57.4% (−3.5 points on a year earlier)

  • Operating margin 57.4%
Jun 2026: operating margin 57.4% (−3.5 points on a year earlier)
QuarterOperating margin
Sep 202361.5%
Dec 2023177.3%
Mar 202459.6%
Jun 202447.3%
Sep 20240.4%
Dec 202456%
Mar 202552.3%
Jun 202560.9%
Sep 202558.2%
Dec 202565.6%
Mar 202658.2%
Jun 202657.4%

Change on a year earlier (points)

  • Change on a year earlier (points) −3.5 pts
Change on a year earlier (points)
QuarterChange on a year earlier (points)
Sep 2023−3.5 pts
Dec 2023+111.4 pts
Mar 2024−3.7 pts
Jun 2024+68.8 pts
Sep 2024−61.1 pts
Dec 2024−121.3 pts
Mar 2025−7.3 pts
Jun 2025+13.6 pts
Sep 2025+57.8 pts
Dec 2025+9.6 pts
Mar 2026+5.9 pts
Jun 2026−3.5 pts
Top: quarterly operating margin, %. Below: change on the same quarter a year earlier, in percentage points. Last 12 quarters. Operating profit as a share of revenue, each quarter.

Is Medical Properties Trust's profit turning into cash?

Over the last 2 years, 100% of Medical Properties Trust, Inc.'s reported profit came in as cash from its operations, so the profit is backed by cash. In FY25 it brought in $231 M of operating cash against −$278 M of profit.

The profit and loss account shows what was earned. The cash-flow statement shows the cash that actually came in. Comparing operating cash flow with profit is one of the best checks that a profit is real.

Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year.

FY25: operating cash $231 M against profit −$278 M; 100% of 2 years' profit came in as cash

  • Operating cash $231 M
  • Net profit −$278 M
FY25: operating cash $231 M against profit −$278 M; 100% of 2 years' profit came in as cash
QuarterOperating cashNet profit
FY21$812 M$654 M
FY22$739 M$901 M
FY23$506 M−$558 M
FY24$245 M−$2.4 B
FY25$231 M−$278 M
Operating cash flow and net profit each year, $ B. The line is free cash flow: operating cash minus spending on assets. 5-year window, yearly figures.

Jun 2026: operating cash $62.4 M

  • Operating cash (quarterly) $62.4 M
Jun 2026: operating cash $62.4 M
QuarterOperating cash (quarterly)
Sep 2023$158 M
Dec 2023$135 M
Mar 2024$74.3 M
Jun 2024$35.3 M
Sep 2024$59.2 M
Dec 2024$76.7 M
Mar 2025$0.4 M
Jun 2025$51.7 M
Sep 2025$18.6 M
Dec 2025$160 M
Mar 2026−$14.3 M
Jun 2026$62.4 M

Operating cash as % of profit

  • Operating cash as % of profit −43%
Operating cash as % of profit
QuarterOperating cash as % of profit
Sep 2023135%
Dec 2023–
Mar 2024–
Jun 2024–
Sep 2024–
Dec 2024–
Mar 2025–
Jun 2025–
Sep 2025–
Dec 2025910%
Mar 2026−43%
Jun 2026–
Top: operating cash each quarter, $ M. Below: operating cash as a % of net profit; 100% means all of the quarter's profit came in as cash. Last 12 quarters.

Why: the cash figure is clear, but the day counts behind it are not in our data, so we show it without guessing the reason.

What to look at next: no single use of cash stands out. The next section checks both the cash tied up in daily operations and the spending on assets.

Where does Medical Properties Trust's cash go?

Medical Properties Trust, Inc. does not report the customer, stock and supplier day counts a cash cycle needs, so this section looks at its spending on assets instead. Nothing is estimated in place of the missing day counts, so no cash-cycle chart is drawn.

Working capital is the cash tied up between paying suppliers and getting paid. Debtor days: how long customers take to pay. Inventory days: how long stock sits. The cash cycle: the whole loop, in days of sales.

In short: neither the daily cycle nor new spending is soaking up the cash, so the picture is fairly clean.

What is Medical Properties Trust's P/E ratio, and how does it compare with its own history?

Medical Properties Trust, Inc.'s P/E is 5.0×, with too little history to compare. This compares the share price with the company’s own past. It does not say what the business is worth.

P/E is the share price divided by a year's profit per share: how many dollars the market pays for each dollar of yearly profit.

P/E 5.0× against a usual —: with too little history to compare

  • P/E 30.4×
P/E 5.0× against a usual —: with too little history to compare
WeekP/E
1 Apr 202211.5×
8 Apr 202211.3×
14 Apr 202210.8×
22 Apr 202210.0×
29 Apr 20229.82×
6 May 20229.84×
13 May 20229.73×
20 May 20229.65×
27 May 20229.93×
3 Jun 20229.26×
10 Jun 20228.54×
17 Jun 20227.67×
24 Jun 20228.27×
1 Jul 20227.83×
8 Jul 20227.80×
15 Jul 20227.89×
22 Jul 20228.28×
29 Jul 20228.63×
5 Aug 20227.95×
12 Aug 20228.37×
19 Aug 20227.98×
26 Aug 20227.49×
2 Sep 20227.17×
9 Sep 20227.43×
16 Sep 20226.91×
23 Sep 20226.25×
30 Sep 20225.70×
7 Oct 20224.88×
14 Oct 20225.22×
21 Oct 20224.91×
28 Oct 20225.57×
4 Nov 20225.41×
11 Nov 20226.03×
18 Nov 20225.95×
25 Nov 20226.29×
2 Dec 20226.25×
9 Dec 20225.67×
16 Dec 20225.48×
23 Dec 20225.36×
30 Dec 20225.36×
6 Jan 20238.27×
13 Jan 20238.58×
20 Jan 20239.18×
27 Jan 20238.74×
3 Feb 20238.56×
10 Feb 20238.09×
17 Feb 20238.67×
24 Feb 20237.06×
3 Mar 20237.04×
10 Mar 20235.88×
17 Mar 20235.17×
24 Mar 20235.04×
31 Mar 202316.6×
6 Apr 202316.4×
14 Apr 202316.7×
21 Apr 202316.8×
28 Apr 202317.7×
5 May 202317.4×
12 May 202315.4×
19 May 202315.5×
26 May 202316.0×
2 Jun 202316.7×
9 Jun 202318.6×
16 Jun 202318.6×
23 Jun 202317.5×
30 Jun 202385.7×
7 Jul 202385.7×
14 Jul 202391.1×
21 Jul 202393.1×
28 Jul 202393.1×
4 Aug 202392.1×
11 Aug 202374.8×
18 Aug 202364.2×
25 Aug 202364.9×
1 Sep 202367.5×
8 Sep 202361.5×
15 Sep 202358.9×
22 Sep 202349.4×
29 Sep 202350.5×
6 Oct 202347.2×
13 Oct 202345.9×
20 Oct 202343.5×
27 Oct 202345.4×
3 Nov 202350.5×
10 Nov 202339.3×
17 Nov 202342.7×
24 Nov 202343.2×
1 Dec 202348.2×
8 Dec 202343.4×
15 Dec 202346.8×
22 Dec 202345.6×
29 Dec 202345.5×
5 Jan 202432.9×
12 Jan 202431.8×
19 Jan 202428.4×
26 Jan 202430.3×
2 Feb 202430.4×

Earnings per share, 12 months

  • Earnings per share, 12 months $0.11
Earnings per share, 12 months
WeekEarnings per share, 12 months
1 Apr 2022–
8 Apr 2022–
14 Apr 2022–
22 Apr 2022–
29 Apr 2022–
6 May 2022–
13 May 2022–
20 May 2022–
27 May 2022–
3 Jun 2022–
10 Jun 2022–
17 Jun 2022–
24 Jun 2022$1.87
1 Jul 2022$1.87
8 Jul 2022$1.87
15 Jul 2022$1.87
22 Jul 2022$1.87
29 Jul 2022$1.87
5 Aug 2022$1.87
12 Aug 2022$1.87
19 Aug 2022$1.87
26 Aug 2022$1.87
2 Sep 2022$1.87
9 Sep 2022$1.87
16 Sep 2022$1.87
23 Sep 2022$1.87
30 Sep 2022$2.08
7 Oct 2022$2.08
14 Oct 2022$2.08
21 Oct 2022$2.08
28 Oct 2022$2.08
4 Nov 2022$2.08
11 Nov 2022$2.08
18 Nov 2022$2.08
25 Nov 2022$2.08
2 Dec 2022$2.08
9 Dec 2022$2.08
16 Dec 2022$2.08
23 Dec 2022$2.08
30 Dec 2022$2.08
6 Jan 2023$2.08
13 Jan 2023$2.08
20 Jan 2023$2.08
27 Jan 2023$2.08
3 Feb 2023$2.08
10 Feb 2023$2.08
17 Feb 2023$2.08
24 Feb 2023$2.08
3 Mar 2023$2.08
10 Mar 2023$2.08
17 Mar 2023$2.08
24 Mar 2023$2.08
31 Mar 2023$0.49
6 Apr 2023$0.49
14 Apr 2023$0.49
21 Apr 2023$0.49
28 Apr 2023$0.49
5 May 2023$0.49
12 May 2023$0.49
19 May 2023$0.49
26 May 2023$0.49
2 Jun 2023$0.49
9 Jun 2023$0.49
16 Jun 2023$0.49
23 Jun 2023$0.49
30 Jun 2023$0.11
7 Jul 2023$0.11
14 Jul 2023$0.11
21 Jul 2023$0.11
28 Jul 2023$0.11
4 Aug 2023$0.11
11 Aug 2023$0.11
18 Aug 2023$0.11
25 Aug 2023$0.11
1 Sep 2023$0.11
8 Sep 2023$0.11
15 Sep 2023$0.11
22 Sep 2023$0.11
29 Sep 2023$0.11
6 Oct 2023$0.11
13 Oct 2023$0.11
20 Oct 2023$0.11
27 Oct 2023$0.11
3 Nov 2023$0.11
10 Nov 2023$0.11
17 Nov 2023$0.11
24 Nov 2023$0.11
1 Dec 2023$0.11
8 Dec 2023$0.11
15 Dec 2023$0.11
22 Dec 2023$0.11
29 Dec 2023$0.11
5 Jan 2024$0.11
12 Jan 2024$0.11
19 Jan 2024$0.11
26 Jan 2024$0.11
2 Feb 2024$0.11
Top: P/E each week. Below: earnings per share, trailing twelve months, a step line that moves once a quarter; 1 year of history; short peaks above 93× are drawn at the top edge.
5.0×P/E · too little history to compare
9.38PEG · today, as reported

In short: there is too little history to say whether the multiple is high or low for this company, so the earnings trend underneath matters more than the multiple.

Is the Medical Properties Trust business getting better or worse?

Medical Properties Trust, Inc.'s business trend cannot be read yet. There are fewer than eight usable quarters of growth figures, so there is not enough history to read the trend. This is based on 12 quarters of 2 measures, with some gaps.

Every business is somewhere on a path of getting better or worse, and this section names where. The last 12 quarters of growth in revenue, profit and earnings per share, plus the return the business earns on its capital, are read as lines. Getting worse: the lines are falling. Turning around: a low point has just formed and the last few quarters are rising from it. Getting better: the rise from the low has lasted. Growing steadily: steady growth with healthy returns. Slowing from a peak: still high, but slowing. When the lines disagree the result is mixed; too little history means no reading. CAGR (compound annual growth rate) is the steady yearly rate that would turn the starting value into the latest one. It is the fairest way to compare growth over different periods. If the 1-year figure is much bigger than the 10-year one, recent growth is running faster than the long-run trend. A dash means there is no figure for that period, or the starting year was a loss, where a growth rate means nothing.

Growth year by year: revenue +2.9% in FY25

  • Revenue growth 2.9%
Growth year by year: revenue +2.9% in FY25
QuarterRevenue growth
FY21–
FY220.7%
FY23−44.1%
FY2417.4%
FY252.9%

Profit growth, EPS growth

  • Profit growth −161.9%
  • EPS growth −162.2%
Profit growth, EPS growth
QuarterProfit growthEPS growth
FY21––
FY2237.8%35.1%
FY23−161.9%−162.2%
FY24––
FY25––
Growth on the year before, each year, %. Top: revenue. Below: net profit and earnings per share, on their own scale because profit growth swings much more. Zero line drawn.

Three growth lines over twelve quarters: revenue rolling over

  • Revenue 12.1%
Three growth lines over twelve quarters: revenue rolling over
QuarterRevenue
Sep 2023−12.1%
Dec 2023−44.1%
Mar 2024−47.2%
Jun 2024−50%
Sep 2024−53.3%
Dec 202417.4%
Mar 202523.5%
Jun 202534.7%
Sep 202552.7%
Dec 20252.9%
Mar 202610.5%
Jun 202612.1%

Profit, EPS

  • Profit −300%
  • EPS −300%
Profit, EPS
QuarterProfitEPS
Sep 2023−102.6%−103.5%
Dec 2023−161.5%−162.9%
Mar 2024−300%−300%
Jun 2024−300%−300%
Sep 2024––
Dec 2024––
Mar 2025––
Jun 2025––
Sep 2025––
Dec 2025––
Mar 2026––
Jun 2026––
Growth on a year earlier, % at each quarter end. Top: revenue. Below: profit and earnings per share, on their own scale because they swing much more. Each is measured over the last 12 months. Extreme jumps from a tiny base are drawn at the edge (▲). A gap means there is no reading for that quarter.

ROCE: the return line, worked out each quarter

  • ROCE 3.6%
ROCE: the return line, worked out each quarter
QuarterROCE
Sep 20233.3%
Dec 2023–
Mar 2024–
Jun 2024–
Sep 2024–
Dec 2024–
Mar 2025–
Jun 2025–
Sep 2025–
Dec 20253.5%
Mar 20263.6%
Jun 20263.6%
Operating profit over the last 12 months (before interest and tax) as a share of average capital employed (total assets minus current liabilities), %.
Turning downRevenue growth · latest +12.1%, range −53.3% to +52.7%
Stuck lowROCE · latest 3.6%, range 3.3% to 3.6%

Why it matters: with too little history, we say so rather than guess a direction.

There are fewer than eight usable quarters, so this page does not guess a direction from so little history.

Compound annual growth rate (%)

Compound annual growth rate over each period, %. Revenue, profit and EPS come from yearly figures; the stock price row is price growth over the same periods. A dash means no figure for that period, or the starting year was a loss.

Compound annual growth rate (%)
Measure1yr3yr5yr10yr
Revenue+2.9%−12.3%——
Stock price−59.6%−27.8%−37.3%−16.3%
+1.9%Revenue growth (Jun 2026) · latest quarter against a year ago
−9.2%Revenue, 4 years · yearly growth over the long run

How much does Medical Properties Trust earn on its capital?

Medical Properties Trust, Inc. earned a ROE of −6% in FY25. That is up from a low of −50% in FY24. Its return on capital used (ROIC) is 1.1 percentage points below its cost of capital, so growth here does not yet pay for the capital it uses.

Return on equity (ROE) is the profit the business earns on its shareholders’ money. We do not have the full capital split, so ROE is the longest history we can draw here.

It comes from a −26.0% net margin and 0.07× asset turnover (sales divided by assets).

Why the return is what it is (FY25): a −26.0% net margin × 0.07× asset turnover × 3.26× leverage (assets divided by equity) ≈ −5.9% on equity. The margin does its share; borrowing is a big part of it.

The key test, return on capital used minus the cost of capital: 4.6% − 5.7% = −1.1 percentage points. The 5.7% is an estimate of this company's own cost of capital. Read the sign and size of the gap, not the decimals. Negative: growth at these returns loses value until returns improve.

FY25: ROE −6%, the climb back from FY24's −50%

  • ROE −6%
  • ROIC (annual) 4.5%
  • Cost of capital 5.7%
FY25: ROE −6%, the climb back from FY24's −50%
QuarterROEROIC (annual)Cost of capital
FY217.7%5.3%5.7%
FY2210.5%5.1%5.7%
FY23−7.3%0.3%5.7%
FY24−49.9%2.7%5.7%
FY25−6%4.5%5.7%
Return on equity each year, % (line); ROIC each year, % (line). 5-year window, low years included. The flat line is the 5.7% cost of capital used on this page.

Jun 2026: ROIC 4.2% (last 12 months) against a 5.7% cost of capital

  • ROIC (12 months) 4.2%
  • ROE (12 months) −10.3%
  • Cost of capital 5.7%
Jun 2026: ROIC 4.2% (last 12 months) against a 5.7% cost of capital
QuarterROIC (12 months)ROE (12 months)Cost of capital
Sep 20233.3%3.2%5.7%
Dec 20233.1%−1.2%5.7%
Mar 20240.3%−28.1%5.7%
Jun 20240.2%−78.5%5.7%
Sep 20241.4%−96.3%5.7%
Dec 20240.4%−157%5.7%
Mar 20252.7%−155.8%5.7%
Jun 20252.6%−116.8%5.7%
Sep 20252.9%−105.2%5.7%
Dec 20254%−56.6%5.7%
Mar 20264%−23%5.7%
Jun 20264.2%−10.3%5.7%
ROIC and ROE over the last 12 months, each quarter, %; the flat line is the cost of capital. Last 12 quarters, lined up with the yearly figure.

Does Medical Properties Trust have too much debt?

Medical Properties Trust, Inc. has total debt of $9.7 B against shareholder equity of $4.5 B as of Jun 2026, so its debt is 2.16× its equity. Year by year, that ratio went from 1.35 in FY21 to 2.12 in FY25. Keep that borrowing in mind when reading the returns on this page.

Debt-to-equity shows how much of the business is paid for with borrowed money. Lower is safer, and the direction matters as much as the level.

FY25: debt $9.8 B, 2.12× equity

  • Total debt $9.8 B
FY25: debt $9.8 B, 2.12× equity
QuarterTotal debt
FY21$11.4 B
FY22$10.4 B
FY23$10.2 B
FY24$8.9 B
FY25$9.8 B

Debt-to-equity

  • Debt-to-equity 2.12×
Debt-to-equity
QuarterDebt-to-equity
FY211.35×
FY221.21×
FY231.33×
FY241.85×
FY252.12×
Top: total debt each year, $ B. Below: debt-to-equity, ×. 5-year window.

Jun 2026: debt $9.7 B, debt-to-equity 2.16

  • Total debt (quarterly) $9.7 B
Jun 2026: debt $9.7 B, debt-to-equity 2.16
QuarterTotal debt (quarterly)
Sep 2023$10.2 B
Dec 2023$10.2 B
Mar 2024$10.1 B
Jun 2024$9.4 B
Sep 2024$9.2 B
Dec 2024$8.9 B
Mar 2025$9.5 B
Jun 2025$9.6 B
Sep 2025$9.6 B
Dec 2025$9.8 B
Mar 2026$9.7 B
Jun 2026$9.7 B

Debt-to-equity

  • Debt-to-equity 2.16×
Debt-to-equity
QuarterDebt-to-equity
Sep 20231.23×
Dec 20231.33×
Mar 20241.51×
Jun 20241.51×
Sep 20241.69×
Dec 20241.85×
Mar 20251.99×
Jun 20252.00×
Sep 20252.06×
Dec 20252.12×
Mar 20262.13×
Jun 20262.16×
Top: total debt each quarter, $ B. Below: debt-to-equity, ×. Last 12 quarters.

What is the Medical Properties Trust shareholding pattern?

30.5% of Medical Properties Trust, Inc.'s tradable shares are in short positions, which are bets that the price will fall, so a large group of traders is betting against it. At normal trading volumes, closing those positions would take about 11.7 days. US companies do not publish a quarter-by-quarter list of owners, so this page uses short interest instead.

There is no quarter-by-quarter list of owners here, so we look at short interest: the share of tradable shares held in short positions, which gain if the price falls.

It is a single reading at one point in time; we do not have its history.

30.5%Short interest · of the tradable float
11.7Days to cover · at typical volumes

Why it is at this level: the figure does not say who has the short positions or why, so we show the level without guessing the story.

How far is Medical Properties Trust from balance-sheet trouble?

For Medical Properties Trust, Inc., the Z-score is not available, so we say so rather than guess one. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. The debt, cash-flow and return sections show the balance-sheet figures we do have, each with its own date.

The Z-score estimates how far a company is from balance-sheet trouble. Above about 3 is safe; below about 1.8 is the danger zone. It was built for manufacturers, so it is not used for banks and lenders.

How does Medical Properties Trust rank in its industry?

42.5 out of 100, rank 13 of 17 in REIT - Healthcare Facilities, with 67% of the evidence available.

Medical Properties Trust, Inc. scores 42.5 out of 100 against the 17 companies it is compared with in REIT - Healthcare Facilities, ranking 13. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.

The four parts add up to the total exactly: 21.7 + 12.2 + 8.6 + 0 = 42.5. This is the same number shown on the industry page; it is worked out once for the whole group and read here.

What would change it: The score would fall if ROA turns down or gross NPA rises while the share price lags its sector.

Which companies is Medical Properties Trust compared with?

Medical Properties Trust ranks 13 of 17 REIT - Healthcare Facilities companies on the 4-Factor Sector Score, with 42.5 out of 100.

  1. 1LTC Properties, Inc.LTC · leader · Most evidence points up · 76% evidence72.5out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 24.3/35 · Income 61% · Profit 61.5% · 71% evidenceCapital efficiency 15.9/25 · ROA 4.2% · ROE 8.5% · GNPA — · 68% evidenceValuation 12.3/20 · P/BV 1.47× · P/BV÷ROE 0.17 · 70% evidenceRelative strength 20.0/20 · Lead over its industry 20.2% · Lead over S&P 500 11.7% · 1 year 29.1% · 100% evidence · 9 of 12 weeks aheadExact sum: 24.3 + 15.9 + 12.3 + 20 = 72.5 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  2. 2Omega Healthcare Investors, Inc.OHI · turning · Most evidence points up · 76% evidence70.2out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 26.1/35 · Income 13.1% · Profit 84.7% · 71% evidenceCapital efficiency 18.9/25 · ROA 5.1% · ROE 11.6% · GNPA — · 68% evidenceValuation 9.5/20 · P/BV 2.52× · P/BV÷ROE 0.22 · 70% evidenceRelative strength 15.7/20 · Lead over its industry 7.1% · Lead over S&P 500 -0.7% · 1 year 12.9% · 100% evidence · 0 of 12 weeks aheadExact sum: 26.1 + 18.9 + 9.5 + 15.7 = 70.2 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks.
  3. 3Strawberry Fields REIT, Inc.STRW · quiet · Evidence leans up · 76% evidence64.7out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 22.4/35 · Income 19.4% · Profit 33.3% · 71% evidenceCapital efficiency 20.1/25 · ROA 6.3% · ROE 74.9% · GNPA — · 68% evidenceValuation 15.0/20 · P/BV 5.66× · P/BV÷ROE 0.08 · 70% evidenceRelative strength 7.2/20 · Lead over its industry 0.3% · Lead over S&P 500 -6.9% · 1 year 12.3% · 100% evidence · 0 of 12 weeks aheadExact sum: 22.4 + 20.1 + 15 + 7.2 = 64.7 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  4. 4Healthpeak Properties, Inc.DOC · quiet · Evidence leans up · 76% evidence56.4out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 16.6/35 · Income 5.5% · Profit 42.5% · 71% evidenceCapital efficiency 11.8/25 · ROA 1.1% · ROE 9.2% · GNPA — · 68% evidenceValuation 12.7/20 · P/BV 1.55× · P/BV÷ROE 0.17 · 70% evidenceRelative strength 15.3/20 · Lead over its industry 8.8% · Lead over S&P 500 1.1% · 1 year 13.2% · 100% evidence · 2 of 12 weeks aheadExact sum: 16.6 + 11.8 + 12.7 + 15.3 = 56.4 · What this means: Relative strength against the index is 1.1%, and revenue and profit growth are weak.
  5. 5Welltower Inc.WELL · turning · Evidence leans up · 80% evidence53.6out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 22.2/35 · Income 39.2% · Profit 73.5% · 81% evidenceCapital efficiency 8.9/25 · ROA 0.9% · ROE 3.9% · GNPA — · 68% evidenceValuation 3.9/20 · P/BV 3.33× · P/BV÷ROE 0.85 · 70% evidenceRelative strength 18.6/20 · Lead over its industry 16.9% · Lead over S&P 500 8.5% · 1 year 30.3% · 100% evidence · 6 of 12 weeks aheadExact sum: 22.2 + 8.9 + 3.9 + 18.6 = 53.6 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  6. 6National Health Investors, Inc.NHI · basing · Evidence leans up · 76% evidence53.0out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 19.5/35 · Income 23.7% · Profit 16.2% · 71% evidenceCapital efficiency 18.0/25 · ROA 4.6% · ROE 10.3% · GNPA — · 68% evidenceValuation 9.0/20 · P/BV 2.33× · P/BV÷ROE 0.23 · 70% evidenceRelative strength 6.5/20 · Lead over its industry -6.1% · Lead over S&P 500 -13.2% · 1 year -7.2% · 100% evidence · 0 of 12 weeks aheadExact sum: 19.5 + 18 + 9 + 6.5 = 53 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  7. 7CareTrust REIT, Inc.CTRE · basing · Evidence leans up · 76% evidence51.7out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 21.6/35 · Income 53.1% · Profit 62.6% · 71% evidenceCapital efficiency 15.8/25 · ROA 4.5% · ROE 7.7% · GNPA — · 68% evidenceValuation 7.6/20 · P/BV 2.11× · P/BV÷ROE 0.27 · 70% evidenceRelative strength 6.7/20 · Lead over its industry -0.6% · Lead over S&P 500 -7.9% · 1 year 5% · 100% evidence · 0 of 12 weeks aheadExact sum: 21.6 + 15.8 + 7.6 + 6.7 = 51.7 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  8. 8Sabra Health Care REIT, Inc.SBRA · turning · Evidence leans down · 76% evidence49.6out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 13.3/35 · Income 17.7% · Profit -63.9% · 71% evidenceCapital efficiency 13.4/25 · ROA 3.2% · ROE 5.8% · GNPA — · 68% evidenceValuation 6.8/20 · P/BV 1.79× · P/BV÷ROE 0.31 · 70% evidenceRelative strength 16.1/20 · Lead over its industry 7.5% · Lead over S&P 500 -0.3% · 1 year 11.7% · 100% evidence · 3 of 12 weeks aheadExact sum: 13.3 + 13.4 + 6.8 + 16.1 = 49.6 · What this means: Relative strength against the index is -0.3%, and revenue and profit growth are weak.
  9. 9American Healthcare REIT, Inc.AHR · turning · Evidence leans down · 67% evidence49.1out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 17.9/35 · Income 16.9% · Profit — · 45% evidenceCapital efficiency 10.4/25 · ROA 1.9% · ROE 2.8% · GNPA — · 68% evidenceValuation 3.8/20 · P/BV 2.69× · P/BV÷ROE 0.96 · 70% evidenceRelative strength 17.0/20 · Lead over its industry 11.8% · Lead over S&P 500 3.8% · 1 year 14.1% · 100% evidence · 5 of 12 weeks aheadExact sum: 17.9 + 10.4 + 3.8 + 17 = 49.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  10. 10Ventas, Inc.VTR · quiet · Evidence leans down · 76% evidence47.1out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 21.3/35 · Income 21.6% · Profit 37.2% · 71% evidenceCapital efficiency 10.7/25 · ROA 2.1% · ROE 1.8% · GNPA — · 68% evidenceValuation 3.4/20 · P/BV 2.84× · P/BV÷ROE 1.58 · 70% evidenceRelative strength 11.7/20 · Lead over its industry 5.8% · Lead over S&P 500 -1.9% · 1 year 17.2% · 100% evidence · 2 of 12 weeks aheadExact sum: 21.3 + 10.7 + 3.4 + 11.7 = 47.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  11. 11Healthcare Realty Trust IncorporatedHR · basing · Too little evidence to rank firmly · 55% evidence46.9out of 100GrowthCapitalValuationRelative
  12. 12Universal Health Realty Income TrustUHT · basing · Evidence leans down · 76% evidence43.2out of 100GrowthCapitalValuationRelative
  13. 13Medical Properties Trust, Inc. this pageMPT · quiet · Evidence leans down · 67% evidence42.5out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 21.7/35 · Income 12.1% · Profit — · 45% evidenceCapital efficiency 12.2/25 · ROA 2.6% · ROE 2.9% · GNPA — · 68% evidenceValuation 8.6/20 · P/BV 0.61× · P/BV÷ROE 0.21 · 70% evidenceRelative strength 0.0/20 · Lead over its industry -55.2% · Lead over S&P 500 -58.7% · 1 year -59.6% · 100% evidence · 0 of 12 weeks aheadExact sum: 21.7 + 12.2 + 8.6 + 0 = 42.5 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  14. 14Community Healthcare Trust IncorporatedCHCT · basing · Evidence leans down · 67% evidence39.4out of 100GrowthCapitalValuationRelative
  15. 15Diversified Healthcare TrustDHC · quiet · Too little evidence to rank firmly · 55% evidence32.6out of 100GrowthCapitalValuationRelative
  16. 16Chiron Real Estate Inc.XRN · quiet · Most evidence points down · 67% evidence30.9out of 100GrowthCapitalValuationRelative
  17. 17Sila Realty Trust, Inc.SILA · Too little evidence to rank firmly · 43% evidence40.2out of 100GrowthCapitalValuationRelative

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. Financial companies use P/BV÷ROE and asset quality; PEG, industrial OPM and ROCE are excluded. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led S&P 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read.

The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section.

Related companies: REIT - Healthcare Facilities, all 17 compared on one page.

Which companies are close to Medical Properties Trust in size?

Medical Properties Trust is the 13th largest of 17 REIT - Healthcare Facilities companies on Sector Alpha by market value (scores of 4 November 2026). Just above it: LTC Properties, Inc., Diversified Healthcare Trust and Sila Realty Trust, Inc. Just below it: Strawberry Fields REIT, Inc., Universal Health Realty Income Trust and Chiron Real Estate Inc.

REIT - Healthcare Facilities companies close in size

  1. LTC Properties, Inc. $2.5 billion
  2. Diversified Healthcare Trust $1.8 billion
  3. Sila Realty Trust, Inc. $1.7 billion
  4. Medical Properties Trust, Inc. $1.2 billion
  5. Strawberry Fields REIT, Inc. $732 million
  6. Universal Health Realty Income Trust $547 million
  7. Chiron Real Estate Inc. $433 million

All 17 REIT - Healthcare Facilities companies, largest first

Companies close in size in other industries

  1. Clear Channel Outdoor Holdings, Inc. $1.2 billion · Advertising Agencies
  2. Universal Technical Institute, Inc. $1.2 billion · Education & Training Services
  3. Medical Properties Trust, Inc. $1.2 billion
  4. CRA International, Inc. $1.2 billion · Consulting Services
  5. Easterly Government Properties, Inc. $1.2 billion · REIT - Office

What else do people ask about Medical Properties Trust?

What were Medical Properties Trust's latest quarterly results?

Medical Properties Trust, Inc. reported revenue of $271 M and a net loss of $2.3 M for the Jun 2026 quarter. Earnings per share were −$0.01. The operating margin was 57.4%, 3.5 percentage points lower than a year earlier (as of 4 November 2026).

What is Medical Properties Trust's market cap?

Medical Properties Trust, Inc.'s market capitalisation is $1.2 B at a stock price of $2.05. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 4 November 2026).

How is Medical Properties Trust performing?

Medical Properties Trust, Inc.'s share price has been falling for 7 weeks. Over the past 13 weeks it has done worse than the S&P 500, for 35 weeks running. This describes what the data did, not a rating (as of 4 November 2026).

Will Medical Properties Trust's stock price go up?

This page does not forecast Medical Properties Trust, Inc.'s stock price. What it shows instead: the stock price is $2.05, and it has been falling for 7 weeks. Nobody can reliably say which way a price will move, and this site does not try (as of 4 November 2026).

Does Medical Properties Trust have too much debt?

Yes, Medical Properties Trust, Inc. has a lot of debt: its debt is 2.00× its equity. A year-by-year history of its borrowings is not in our data, so this uses the latest reading. Keep that borrowing in mind when reading the returns on this page (as of 4 November 2026).

Is Medical Properties Trust's profit real cash?

Yes, over the last 2 years, 100% of Medical Properties Trust, Inc.'s reported profit came in as cash from operations. The latest year was lower at -83%, so the trend is worth watching. In FY25, operating cash was $231 M against reported profit of −$278 M.

Most of that cash then goes into a mix of the daily operating cycle and new capacity. These are yearly figures (as of 4 November 2026).

Where is Medical Properties Trust in its business cycle?

Medical Properties Trust, Inc.'s FY25 operating margin was 59.6%, against a 5-year range of 6.5% to 67.8%: the middle of its own range, neither a peak nor a low. The latest quarter was 57.4%.

Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 4 November 2026).

What could break the Medical Properties Trust story?

Biggest thing to watch: the price is not yet in a clear uptrend, so timing is the risk more than the business.

On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 4 November 2026).

Is Medical Properties Trust a stock worth studying right now?

What the numbers show: Medical Properties Trust, Inc.'s share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. The main open question: the next one or two quarters of results.

Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 4 November 2026).

Where do these numbers come from?

Sector Alpha, written by code from the published numbers. Data as of 4 November 2026.

Every chart on this page is drawn by code from the published figures, with no forecasts and no price opinions.

See the plain-text version of this page.

More lists

Every Sector Alpha list, grouped

X · Instagram · YouTube · About · Newsletter · Newsletter archive
This is research, not advice. We’re not SEBI-registered.